Compounds > methysergide
Page last updated: 2024-08-21

methysergide and zolmitriptan

methysergide has been researched along with zolmitriptan in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Audia, JE; Krushinski, JH; Lucaites, VL; Nelson, DL; Schaus, JM; Wainscott, DB; Zgombick, JM1
Henry, P1
Vaitkus, A; Vilionskis, A1
Baudoin, Y; Guilhem, K; Meyrat, L; Thouard, H1

Reviews

1 review(s) available for methysergide and zolmitriptan

ArticleYear
[The problems of migraine headache treatment].
    Medicina (Kaunas, Lithuania), 2002, Volume: 38, Issue:7

    Topics: Aged; Analgesics; Analgesics, Non-Narcotic; Aspirin; Dihydroergotamine; Female; Humans; Male; Methysergide; Migraine Disorders; Oxazolidinones; Serotonin Antagonists; Serotonin Receptor Agonists; Stress, Psychological; Sumatriptan; Time Factors; Tryptamines; Vasoconstrictor Agents

2002

Other Studies

4 other study(ies) available for methysergide and zolmitriptan

ArticleYear
[3H]LY334370, a novel radioligand for the 5-HT1F receptor. I. In vitro characterization of binding properties.
    Naunyn-Schmiedeberg's archives of pharmacology, 2005, Volume: 371, Issue:3

    Topics: Animals; Benzamides; Brain; Cells, Cultured; Guanosine 5'-O-(3-Thiotriphosphate); Guinea Pigs; Humans; In Vitro Techniques; Indoles; Ligands; Radioligand Assay; Rats; Receptor, Serotonin, 5-HT1F; Receptors, Serotonin; Serotonin Receptor Agonists; Transfection; Tritium

2005
New "triptans" and other drugs for migraine.
    The Medical letter on drugs and therapeutics, 1998, Oct-09, Volume: 40, Issue:1037

    Topics: Adrenergic beta-Antagonists; Amitriptyline; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Tricyclic; Calcium Channel Blockers; Dihydroergotamine; Drug Interactions; Ergotamine; Humans; Indoles; Methysergide; Migraine Disorders; Naproxen; Oxazoles; Oxazolidinones; Piperidines; Propranolol; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Timolol; Triazoles; Tryptamines; Valproic Acid; Vasoconstrictor Agents

1998
[Migraine: a disease, not a symptom].
    La Revue du praticien, 2002, Jan-01, Volume: 52, Issue:1

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Analgesics; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Atenolol; Diagnosis, Differential; Dihydroergotamine; Flunarizine; GABA Agents; Humans; Indoramin; Methysergide; Migraine Disorders; Oxazolidinones; Serotonin Antagonists; Serotonin Receptor Agonists; Tryptamines; Valproic Acid; Vasoconstrictor Agents; Vasodilator Agents

2002
Images of an occlusive arterial disease of lower extremity due to chronic intoxication by ergot alkaloid.
    Journal of vascular surgery, 2014, Volume: 60, Issue:3

    Topics: Arterial Occlusive Diseases; Clopidogrel; Drug Substitution; Female; Humans; Lower Extremity; Methysergide; Middle Aged; Migraine Disorders; Oxazolidinones; Platelet Aggregation Inhibitors; Predictive Value of Tests; Serotonin 5-HT1 Receptor Agonists; Ticlopidine; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Tryptamines; Vasoconstrictor Agents

2014